- Home
- BWAY vs SFST Comparison
BWAY vs SFST Comparison
Compare BWAY & SFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWAY
- SFST
- Stock Information
- Founded
- BWAY 2003
- SFST 1999
- Country
- BWAY Israel
- SFST United States
- Employees
- BWAY N/A
- SFST N/A
- Industry
- BWAY Medical/Dental Instruments
- SFST Major Banks
- Sector
- BWAY Health Care
- SFST Finance
- Exchange
- BWAY Nasdaq
- SFST Nasdaq
- Market Cap
- BWAY 280.7M
- SFST 335.4M
- IPO Year
- BWAY 2019
- SFST 1999
- Fundamental
- Price
- BWAY $15.44
- SFST $51.15
- Analyst Decision
- BWAY Strong Buy
- SFST Buy
- Analyst Count
- BWAY 2
- SFST 1
- Target Price
- BWAY $20.50
- SFST $51.00
- AVG Volume (30 Days)
- BWAY 65.4K
- SFST 26.1K
- Earning Date
- BWAY 11-11-2025
- SFST 10-28-2025
- Dividend Yield
- BWAY N/A
- SFST N/A
- EPS Growth
- BWAY 213.09
- SFST 86.78
- EPS
- BWAY 0.13
- SFST 3.23
- Revenue
- BWAY $49,094,000.00
- SFST $109,391,000.00
- Revenue This Year
- BWAY N/A
- SFST $13.23
- Revenue Next Year
- BWAY N/A
- SFST $17.49
- P/E Ratio
- BWAY $47.75
- SFST $15.86
- Revenue Growth
- BWAY 27.08
- SFST 21.32
- 52 Week Low
- BWAY $7.84
- SFST $29.14
- 52 Week High
- BWAY $17.92
- SFST $52.64
- Technical
- Relative Strength Index (RSI)
- BWAY 48.93
- SFST 73.56
- Support Level
- BWAY $14.27
- SFST $47.01
- Resistance Level
- BWAY $15.56
- SFST $52.60
- Average True Range (ATR)
- BWAY 0.82
- SFST 1.69
- MACD
- BWAY -0.10
- SFST 0.29
- Stochastic Oscillator
- BWAY 51.44
- SFST 83.14
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
About SFST Southern First Bancshares Inc.
Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.